ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.

Quote:

Search for Ticker

Free Membership

Search:

ALLI: Allion Healthcare Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

ALLION HEALTHCARE INC (NASD)
ALLI	6.52	N/A	(N/A%)	Vol. 0	N/A ET

Allion Healthcare, Inc. is a national provider of specialty pharmacy and disease management services focused on HIV/AIDS patients. Allion Healthcare sells HIV/AIDS medications, ancillary drugs and nutritional supplies under the trade name MOMS Pharmacy.

General Information

ALLION HEALTHCR

1660 Walt Whitman Road Suite 105 Melville, NY 11747 Phone: 631-547-6520 Fax: - Web: www.allionhealthcare.com Email: None

Industry	MED-WHSL DRG/SN
Sector:	Retail/Wholesale

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	11/23/2009

Price and Volume Information

Zacks Rank
Yesterday's Close	6.52
52 Week High	7.74
52 Week Low	2.70
Beta	1.39
20 Day Moving Average	198,032.09
Target Price Consensus	8.2

% Price Change
4 Week	1.24
12 Week	-10.32
YTD	58.25

% Price Change Relative to S&P 500
4 Week	0.15
12 Week	-15.45
YTD	30.97

Share Information
Shares Outstanding (millions)	28.67
Market Capitalization (millions)	186.92
Short Ratio	3.66
Last Split Date	N/A

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	0.12
Current Year EPS Consensus Estimate	0.49
Estimated Long-Term EPS Growth Rate	14.50
Next EPS Report Date	11/23/2009

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	2.00
30 Days Ago	2.00
60 Days Ago	1.33
90 Days Ago	1.33

Fundamental Ratios

P/E
Current FY Estimate:	13.20
Trailing 12 Months:	12.78
PEG Ratio	0.91

EPS Growth
vs. Previous Year	27.27%
vs. Previous Quarter	7.69%

Sales Growth
vs. Previous Year	15.30%
vs. Previous Quarter:	3.18%

Price Ratios
Price/Book	0.89
Price/Cash Flow	10.35
Price / Sales	-

ROE
09/30/09	-
06/30/09	7.94
03/31/09	7.58

ROA
09/30/09	-
06/30/09	4.69
03/31/09	4.52

Current Ratio
09/30/09	-
06/30/09	2.81
03/31/09	2.63

Quick Ratio
09/30/09	-
06/30/09	2.35
03/31/09	2.19

Operating Margin
09/30/09	-
06/30/09	3.59
03/31/09	3.40

Net Margin
09/30/09	-
06/30/09	5.76
03/31/09	5.63

Pre-Tax Margin
09/30/09	-
06/30/09	5.76
03/31/09	5.63

Book Value
09/30/09	-
06/30/09	7.29
03/31/09	6.60

Inventory Turnover
09/30/09	-
06/30/09	22.81
03/31/09	22.13

Debt-to-Equity
09/30/09	-
06/30/09	0.41
03/31/09	0.31

Debt to Capital
09/30/09	-
06/30/09	28.89
03/31/09	23.64


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research